EUVIMEDEUVIMED entdecken
Crossref

Purinergic system in the pathogenesis and treatment of mood disorders

Magda K. Malewska, Filip Rybakowski, Janusz Rybakowski

Pharmacotherapy in Psychiatry and Neurology · 2024 · 40 (1) · 43-52

DOI: 10.5114/fpn.2024.140848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacotherapy in Psychiatry and Neurology, 2024. Verfasst von Magda K. Malewska und 2 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

a higher prevalence of gout and higher uric acid levels in patients with bipolar disorder (BD), especially during a manic episode, and lower concentration of this acid in depression.It was found that adenosine and its receptors, as well as the P2X 2 nucleotide receptor may have pathogenic importance in BD and depression.The P2X 2 receptor moderates an inflammatory response.In the clinical conditions, it was found that allopurinol, which lowers uric acid concentration, has shown therapeutic effects on mania when used as an addition to mood stabilisers.In animal models, antidepressant effects of A 2A and P2X 7 receptor antagonists have been observed. Conclusions.The article discusses purinergic mechanisms and identifies key targets in the pathogenesis and pharmacotherapy of mood disorders that merit further research.It highlights the importance of uric acid concentration and the modulation of adenosine receptor A 2A and receptor P2X 7 .Future research is needed to elucidate the usefulness, safety, and efficacy of drugs targeting purinergic activity, such as allopurinol and A 2A and P2X 7 receptor antagonists. StreSzczenieCel. Celem pracy jest przedstawienie roli układu purynergicznego w patogenezie i leczeniu chorób afektywnych.Przegląd piśmiennictwa.W skład układu purynergicznego wchodzą m.in.: kwas moczowy, receptory P1, których agonistą jest adenozyna, oraz receptory P2 AbStrAct Objectives.The study aims to present the role of the purinergic system in the pathogenesis and treatment of mood disorders.Literature review.The purinergic system includes, among others, uric acid, P1 receptors whose agonist is adenosine, and P2 receptors activated by nucleotides (including adenosine triphosphate, ATP).Accumulated evidence indicates that these factors play a role in the pathogenesis of mood disorders.The studies show

Zitieren

APA

Malewska, M. K., Rybakowski, F., & Rybakowski, J. (2024). Purinergic system in the pathogenesis and treatment of mood disorders. Pharmacotherapy in Psychiatry and Neurology, 40(1), 43-52. https://doi.org/10.5114/fpn.2024.140848

Vancouver

Malewska MK, Rybakowski F, Rybakowski J. Purinergic system in the pathogenesis and treatment of mood disorders. Pharmacotherapy in Psychiatry and Neurology. 2024;40(1):43-52. doi:10.5114/fpn.2024.140848

BibTeX
@article{Malewska2024,
  author = {Malewska, Magda K. and Rybakowski, Filip and Rybakowski, Janusz},
  title = {Purinergic system in the pathogenesis and treatment of mood disorders},
  journal = {Pharmacotherapy in Psychiatry and Neurology},
  year = {2024},
  volume = {40},
  number = {1},
  pages = {43--52},
  doi = {10.5114/fpn.2024.140848}
}
Kostenlos starten →